The Covid-19 antibody drug bamlanivimab which is effective against the new virus variant originally discovered in the UK will arrive in Hungary on Wednesday.
Miklós Kásler, Minister of Human Resources, said on Facebook that Hungary will be the first European country that can use bamlanivimab, developed by US drugmaker Eli Lilly. He added that the National Institute of Pharmacy and Nutrition (OGYÉI) approved the drug on December 12 for emergency, temporary use and the operative body responsible for the epidemic approved its acquisition. As a result, the Hungarian government was first to sign an agreement with the manufacturer in line with which a total of 6,236 ampoules are expected to arrive in three stages by the end of March.
The ministry said that 2,400 ampoules are expected to arrive on Wednesday, to be followed by 2,800 ampoules in the second half of February and 1,000 in the second half of March. The statement cites that bamlanivimab can reduce the development of serious complications from coronavirus by 70-75 percent and the affected patients therefore need not be hospitalized.